TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Steady progress made in vaccine development

  • Ardila Syakriah

    Jakarta

Jakarta   /   Wed, August 5 2020   /  01:00 am
Illustration of a vaccine(Shutterstock/PhotobyTawat)

As Indonesia struggles to contain the COVID-19 epidemic, the country, like many others, is pinning its hopes on vaccine development. Indonesia is looking to secure access to candidate vaccines, with its diplomats and local companies seeking cooperation with producers such as Sinovac Biotech of China and Genexine Inc. of South Korea, as well as the Bill Gates-backed Coalition for Epidemic Preparedness Innovations (CEPI). Meanwhile, for a longer-term, self-sufficient strategy, a national consortium under the Research and Technology Ministry is working on developing its own vaccine, helmed by the Eijkman Institute for Molecular Biology. The vaccine will be named after Indonesia's flag colors, Merah Putih, or red and white. All of these attempts are progressing at different paces, while also offering various timelines, production targets and types of vaccines. But they are expec...